Method Article

Electroacupuncture as an Adjuvant Therapy for Dyspnea in Patients with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

DOI:

10.3791/68309

July 22nd, 2025

In This Article

Summary

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This protocol describes a therapeutic approach using electroacupuncture to relieve dyspnea in patients with pulmonary hypertension with chronic obstructive pulmonary disease.

Abstract

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Pulmonary hypertension (PH) is the most prevalent cardiovascular complication of chronic obstructive pulmonary disease (COPD). Dyspnea is the most prevalent and distressing symptom in Pulmonary Hypertension Associated with COPD (PH-COPD) patients. This study elucidates the operational details of electroacupuncture therapy, encompassing instrument preparation, acupuncture point selection, procedure, precautions, and emergency handling. By assessing with the Modified Medical Research Council Dyspnea Scale (mMRC), the 6-Minute Walk Test (6MWT), the Modified Borg Scale, the UCSD Shortness of Breath Questionnaire (UCSD-SOBQ), and the oxygen partial pressure in arterial blood (PaO2), the efficacy and safety of electroacupuncture as a supplementary intervention for dyspnea in patient with PH-COPD were explored.

An exploratory randomized controlled study was conducted on 14 patients, with the electroacupuncture group receiving both conventional therapy and electroacupuncture treatment, and the control group receiving only conventional therapy. After 2 weeks, dyspnea improved in both groups, with the electroacupuncture group showing superior results. No serious adverse reactions occurred in either group. The study indicates that electroacupuncture can effectively alleviate dyspnea in PH-COPD patients, enhance their quality of life, and is simple, safe to operate, and worthy of further investigation and promotion, offering an effective adjunct therapy for PH-COPD.

Introduction

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Chronic Obstructive Pulmonary Disease (COPD) is defined by persistent respiratory symptoms and airflow limitation. Due to abnormalities in the airways and/or alveoli, patients usually experience symptoms such as dyspnea, excessive sputum, and chronic cough1. As the disease progresses, pulmonary hypertension (PH) is the most prevalent cardiovascular consequence in patients with COPD2. PH arises from pulmonary vascular remodeling triggered by long-term airway inflammation and hypoxia. It will further exacerbate patients' dyspnea and lead to an increase in the load on the right ventricle, which may eventually result in ....

Access restricted. Please log in or start a trial to view this content.

Protocol

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The clinical study protocol underwent review and approval by the Clinical Research Approval Committee of Chengdu Xinjin District Hospital of Traditional Chinese Medicine (NO. 202411). All participants were informed of the objectives and procedures of this research and consented to photographic and video recording.

1. Clinical information

  1. Source of cases
    1. Identify observed cases as hospitalized patients in the respiratory and cardiovascular departments of Chengdu Xinjin District Hospital of Traditional Chinese Medicine and the Hospital of Chengdu University of Traditional Chinese Medicine.
    ....

Access restricted. Please log in or start a trial to view this content.

Results

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Fourteen patients were included in this research, with seven assigned to the experimental group and seven to the control group. No participants withdrew during the study, and all 14 completed the protocol. Two males and five females were enrolled in the experimental group. In the control group, there were three males and four females. Table 2 shows the results of the comparison between the control and the experimental groups for variables, including age, sex, body mass in.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This study found that electroacupuncture therapy significantly alleviated dyspnea and improved life quality in PH-COPD patients. Results revealed that the- experimental group exhibited significantly greater improvement than the control group in 6MWT, UCSD-SOBQ, Modified Borg Scale scores, and PaO2 following intervention. This suggests that the treatment regimen received by the experimental group had a positive effect on improving the patient's ability to walk, reducing symptoms of shortness of breath, and .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

The authors have no conflicts of interest to disclose.

Acknowledgements

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

This research was supported by the Sichuan Science and Technology Program (2023ZYD0050, 2024NSFJQ0059), Special subject of scientific research of Sichuan Administration of Traditional Chinese Medicine (2023MS608, 2024zd005), 2022 "Tianfu Qingcheng Plan" Tianfu Science and Technology Leading Talents Project (Chuan Qingcheng No. 1090).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
75% alcoholShenzhen Baoke Medical Devices Co., Ltd.20182140792
alligator clipsBozhou Rongjian Medical Supplies Co., Ltd.2300442G5
disposable sterile acupuncture needlesSuzhou Medical Supplies Factory Co., Ltd.100014261834
IBM SPSS Statistics 25.0IBM Corp./
lead wiresBozhou Rongjian Medical Supplies Co., Ltd.2300442G5
pulsed acupuncture therapeutic device Bozhou Rongjian Medical Supplies Co., Ltd.2300442G5
Sterile cotton swabsChengdu Zhongxin Hygiene Materials Co., Ltd.20240420
The R Programming Language 4.3.2The R Foundation./

References

Loading...
$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,
  1. Global strategy for prevention, diagnosis and management of COPD: 2025 report. , Global Initiative for Chronic Obstructive Lung Disease (GOLD). https://goldcopd.org/2025-gold-report/ (2025).
  2. Morrell, N. W., et al. Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease. Respir Res. 6 (1), 88(2005).
  3. Humbert,....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Tags

Electroacupuncture TherapyPulmonary HypertensionChronic Obstructive PulmonaryDyspnea ManagementAdjuvant TherapyModified Borg ScaleSix Minute WalkArterial Blood OxygenRandomized Controlled StudyAcupuncture Point Selection
Video Coming Soon

Related Articles